How do I find out if I qualify for a hematopoietic and lymphatic system neoplasm study in Connecticut?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Connecticut to take part?

Not necessarily. These studies have a site in Connecticut, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a hematopoietic and lymphatic system neoplasm trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Connecticut

Hematopoietic and Lymphatic System Neoplasm clinical trials in Connecticut

We’re tracking 4 recruiting hematopoietic and lymphatic system neoplasm studies with a site in Connecticut — including Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Connecticut

NCT06410209RecruitingPhase 2
Walking Juntos: Smartphone program to help Hispanic cancer survivors be active
This study will test if a smartphone program and social media group can help Hispanic/Latino teens and young adults who had childhood cancer become more physically active. You would wear a Fitbit and use a phone app with culturally tailored tips and support.
New Haven, ConnecticutAges 15–20
NCT06513962RecruitingPhase 3
Triptorelin to protect ovaries in young women with cancer
This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.
Hartford, ConnecticutAges Up to 39 years
NCT05691491RecruitingPhase 1/Phase 2
Temozolomide plus M1774 for advanced metastatic cancers
This Phase 1/2 trial tests a combination of temozolomide and M1774 to see how safe it is and whether it can help shrink advanced cancers that have spread. It focuses on certain tumor types and specific biomarker results, and it may be an option if standard treatments have been tried or aren’t possible.
New Haven, ConnecticutAges 18 years+
NCT02474160Recruiting
Banking cancer tissue and blood for future research
This study collects and stores leftover or newly taken samples of tissue and blood from people with cancer. The goal is to build a research library that can help investigators study cancer and develop better tests or treatments.
New Haven, ConnecticutAges 2 months+

Hematopoietic and Lymphatic System Neoplasm trials by city in Connecticut

Hartford

Where these studies are running in Connecticut

Institutions with a site for the recruiting hematopoietic and lymphatic system neoplasm studies listed above.

Yale University · 3 studies
Connecticut Children's Medical Center
Smilow Cancer Hospital
Smilow Cancer Hospital Care Center-Trumbull

What taking part in a hematopoietic and lymphatic system neoplasm study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Hematopoietic and Lymphatic System Neoplasm trials in other states

Common questions

Are there hematopoietic and lymphatic system neoplasm clinical trials in Connecticut?: Yes. We're currently tracking 4 recruiting hematopoietic and lymphatic system neoplasm studies with a site in Connecticut, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a hematopoietic and lymphatic system neoplasm study in Connecticut?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Connecticut to take part?: Not necessarily. These studies have a site in Connecticut, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a hematopoietic and lymphatic system neoplasm trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New hematopoietic and lymphatic system neoplasm studies open in Connecticut regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.